Alibaba Unveils Enhanced Zhenwu AI Chip and NextGeneration Large Language Model Could Stock Market Investments Rescue Social Security New Research Suggests Limitations Putin and Xi Set to Discuss LongStalled Power of Siberia 2 Pipeline Amid Iran Conflicts Energy Shockwaves Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth UK Police Chiefs Call for Social Media Block on Under16s Over Safety Risks Ubisoft Shares Dip as Assassins Creed Developer Warns of Continuing Losses BNED Q4 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally Haemonetics Q1 2026 Earnings EPS Slightly Exceeds Estimates Stock Rises 57 TechPrecision Corporation TPCS Q1 2026 Earnings WiderThanExpected Loss Pressures Shares ARCO Q1 2026 Earnings Strong EPS Beat Overshadowed by Stock Decline Brookfield Renewable Corporation Q1 2026 Earnings EPS Misses Estimates as Renewable Energy Market Faces Headwinds Lazard Inc LAZ Q1 2026 Earnings EPS Misses Estimates as Earnings Decline 18 American Exceptionalism Acquisition Corp A AEXA Holds Near Resistance Amid Modest Decline Oatly Group OTLY Slides 177 as Shares Test Key Support Levels The Hartford Insurance Group HIG Edges Lower Consolidation Within Established Technical Range CEA Industries Warrant BNCWW Holds Steady at 003 Amid Flat Trading Smith Douglas Homes Corp SDHC Gains Ground Approaching Key Resistance PRDO Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Despite Opaque Revenue Picture Satellos Bioscience Inc MSLE Q1 2026 Earnings EPS Beat with 1358 Surprise Stock Declines 546 CBRE Q1 2026 Earnings Strong EPS Beat Amid Resilient Commercial Real Estate Market Sonida Senior Living SNDA Q1 2026 Earnings EPS Misses Estimates by 555 Amid Operational Challenges Belden Inc Q1 2026 Earnings EPS Surpasses Estimates Stock Slips VFF Q1 2026 Earnings EPS Misses Estimates Amid Lack of Revenue Disclosure Southeast Asias Biofuel Push Strains Food Supplies and Export Capacity ASUR Q1 2026 Earnings EPS Surpasses Estimates by 183 Recurring Revenue Growth Drives Profitability Jasper Therapeutics JSPR Edges Higher SmallCap Biotech Tests Resistance at 095